![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
COVID-19, host response treatment, and the need for political leadership
Health officials and scientists have warned that we face the threat of a potentially devastating influenza pandemic. Instead, we are now in the midst of a global coronavirus (COVID-19) pandemic. National and i...
-
Article
What treating Ebola means for pandemic influenza
Almost all new treatments being developed for the next influenza pandemic target the virus. During the Ebola crisis in West Africa, patients were treated with an inexpensive generic statin/angiotensin receptor...
-
Article
Immunomodulatory adjunctive treatment options for Ebola virus disease patients: another view
-
Article
Open AccessThe dysfunctional host response to influenza A H7N9: a potential treatment option?
The newly emerging human pathogen influenza A H7N9 represents a potentially major threat to human health. The virus was first shown to be pathogenic in humans in 2013, and outbreaks continue to occur in China ...
-
Article
Commentary: From Scarcity to Abundance: Pandemic Vaccines and Other Agents for “Have Not” Countries
The recent impasse between the Indonesian Ministry of Health and the World Health Organization (WHO) over sharing H5N1 viruses in return for access to affordable pandemic vaccines highlights slow progress in d...
-
Article
Preparing for Pandemic Vaccination: An International Policy Agenda for Vaccine Development
The international use of influenza vaccine is growing, especially in develo** countries. Since 1997, avian H5N1 influenza in Southeast Asia has caused several human infections and high mortality. Experts war...
-
Article
Pneumococcal Vaccination for Older Adults
During the 20 years following its licensure, pneumococcal vaccine has not been widely used. Although the vaccine was shown to be efficacious in South African gold miners, clinical trials of ‘pneumonia vaccine’...
-
Article
Influenza Vaccination in 29 Countries
Objective: This report updates for 1996 and 1997 our 2 earlier reports on the use of influenza vaccination in various countries.
-
Article
Workshop 3: Antivirals and Vaccination for Influenza
-
Article
Japan lagging in influenza jabs
-
Chapter
Adult Immunization
Among all of the challenges of clinical preventive medicine, immunization offers the most clear-cut benefits and greatest likelihood for success. Nonetheless, vaccines often are not regarded as examples of hig...